Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Contraline, Inc.

Contraline, Inc.

Stage unknownCharlottesville, VAcontraline.comBiotechnology

Biotechnology company pioneering reversible male contraception. Our products, NES/T and ADAM, are daily and long-lasting options in clinical testing today.

Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
7
Financing history
1 rounds
  1. May 29, 2026
    Form D equity offering · $55.8M (form d sold) · 77 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Contraline, Inc. filed Form D: $55,804,741 sold of $115,929,658, Biotechnology”
Investors on record
8 edges
People
1 officers, 3 directors
Timeline
2
  1. Sep 16, 2026
    Contraline, Inc. no longer listed on Amboy Street Ventures, LLC's portfolio page
    Removed from portfolio page Inference Venture organization websites (about, team, portfolio, thesis, news pages)
  2. Jun 10, 2026
    Contraline, Inc. filed Form D: $55,804,741 sold of $115,929,658, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
21 observations
Every observation on this company